666

LUSHANG FREDA PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪8.01 B‬CNY
‪303.39 M‬CNY
‪4.54 B‬CNY
‪436.04 M‬
Beta (1Y)
1.54

About LUSHANG FREDA PHARMACEUTICAL

Sector
CEO
Chun Ming Gao
Headquarters
Jinan
Employees (FY)
‪3.65 K‬
Founded
1993
ISIN
CNE000001147
FIGI
BBG000DM5DM8
Lushang Freda Pharmaceutical Co., Ltd. engages in real estate activities. The company focuses on developing and managing real estate, property management, construction, installation, and architectural decoration. It also operates biomedicine and ecological health industry development. The company was founded on April 21, 1993 and is headquartered in Jinan, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 600223 is 7.80 CNY — it has decreased by 1.02% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange LUSHANG FREDA PHARMACEUTICAL stocks are traded under the ticker 600223.
LUSHANG FREDA PHARMACEUTICAL is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
600223 stock is 2.85% volatile and has beta coefficient of 1.54. Check out the list of the most volatile stocks — is LUSHANG FREDA PHARMACEUTICAL there?
One year price forecast for LUSHANG FREDA PHARMACEUTICAL has a max estimate of 13.00 CNY and a min estimate of 9.22 CNY.
600223 earnings for the last quarter are 0.05 CNY per share, whereas the estimation was 0.08 CNY resulting in a −37.50% surprise. The estimated earnings for the next quarter are 0.04 CNY per share. See more details about LUSHANG FREDA PHARMACEUTICAL earnings.
Yes, you can track LUSHANG FREDA PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
600223 stock has fallen by 3.70% compared to the previous week, the month change is a 19.50% fall, over the last year LUSHANG FREDA PHARMACEUTICAL has showed a 28.96% decrease.
600223 net income for the last quarter is ‪65.35 M‬ CNY, while the quarter before that showed ‪47.61 M‬ CNY of net income which accounts for 37.27% change. Track more LUSHANG FREDA PHARMACEUTICAL financial stats to get the full picture.
Today LUSHANG FREDA PHARMACEUTICAL has the market capitalization of ‪8.01 B‬, it has decreased by 4.18% over the last week.
LUSHANG FREDA PHARMACEUTICAL dividend yield was 1.04% in 2023, and payout ratio reached 33.51%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 600223 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUSHANG FREDA PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
600223 reached its all-time high on May 31, 2021 with the price of 19.10 CNY, and its all-time low was 1.94 CNY and was reached on May 8, 2006.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪3.65 K‬ employees. See our rating of the largest employees — is LUSHANG FREDA PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUSHANG FREDA PHARMACEUTICAL technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUSHANG FREDA PHARMACEUTICAL stock shows the sell signal. See more of LUSHANG FREDA PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LUSHANG FREDA PHARMACEUTICAL future price: according to them, 600223 price has a max estimate of 13.00 CNY and a min estimate of 9.22 CNY. Read a more detailed LUSHANG FREDA PHARMACEUTICAL forecast: see what analysts think of LUSHANG FREDA PHARMACEUTICAL and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUSHANG FREDA PHARMACEUTICAL EBITDA is ‪383.37 M‬ CNY, and current EBITDA margin is 8.44%. See more stats in LUSHANG FREDA PHARMACEUTICAL financial statements.